Internal Medicine, Endocrinology, Diabetes, & Metabolism · Troy, MI
NPI
1801897814
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
750 Stephenson Hwy, 235 Bbc
Troy, MI, 48083
Phone (248) 577-3522
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
749 services
Medicare patients, 2024
241
Average age 74
Drug cost, 2024
$144K
1,805 prescriptions
Company payments, 2025
$562
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sheldon S Stoffer was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 338 times for 214 patients. In total Sheldon S Stoffer billed 749 services in 7 codes, and Medicare paid $31K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 338 | 214 | $12.35 | $4,175 |
| 99214 Office E&M - Established | Office | 329 | 198 | $64.57 | $21K |
| 99213 Office E&M - Established | Office | 65 | 54 | $45.07 | $2,930 |
| 99205 Office E&M - New | Office | 13 | 13 | $145.30 | $1,889 |
By year: 2022 $29K for 503 services; 2023 $31K for 482 services; 2024 $31K for 749 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sheldon S Stoffer prescribed most often to Medicare patients was Levothyroxine Sodium, with 424 prescriptions and refills. In total Sheldon S Stoffer wrote 1,805 Medicare prescriptions that cost $144K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 424 | 1,077 | 121 | $4,546 |
| Unithroid Levothyroxine Sodium | 417 | 1,141 | 125 | $14K |
| Synthroid Levothyroxine Sodium | 238 | 667 | 67 | $26K |
| Metformin Hcl Er Metformin Hcl | 86 | 240 | 28 | $1,269 |
| Atorvastatin Calcium Generic | 80 | 210 | 20 | $907 |
| Methimazole Generic | 80 | 210 | 31 | $1,898 |
| Rosuvastatin Calcium Generic | 53 | 147 | 17 | $463 |
| Ezetimibe Generic | 37 | 107 | 12 | $504 |
| Indapamide Generic | 36 | 93 | 11 | $842 |
| Ozempic Semaglutide | 33 | 39 | Under 11 | $34K |
| Levoxyl Levothyroxine Sodium | 30 | 69 | Under 11 | $620 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 29 | 80 | Under 11 | $326 |
| Januvia Sitagliptin Phosphate | 21 | 39 | Under 11 | $20K |
| Hydrocortisone Generic | 21 | 49 | Under 11 | $1,616 |
| Trandolapril Generic | 18 | 48 | Under 11 | $433 |
Brand drugs: 910 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sheldon S Stoffer $562 ($562 in general payments such as food, travel and fees) from 12 companies. The largest payer was Lilly USA, LLC with $173.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 11 | $173 |
| Amgen Inc. AMGN | 4 | $66.19 |
| Abbott Laboratories ABT | 3 | $64.86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61.51 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $45.42 |
| Abbvie Inc. ABBV | 2 | $34.11 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $23.83 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $22.21 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $17.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.